These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The diagnosis and management of benzodiazepine dependence. Ashton H Curr Opin Psychiatry; 2005 May; 18(3):249-55. PubMed ID: 16639148 [TBL] [Abstract][Full Text] [Related]
23. [Experiences from a department of general psychiatry. Detoxication of patients with benzodiazepine dependence]. Vikander B; Lindroth A; Tönne U; Borg S Lakartidningen; 1987 Oct; 84(41):3276-8. PubMed ID: 2890804 [No Abstract] [Full Text] [Related]
25. Acceptability of cognitive-behaviour therapy via the Internet for cessation of benzodiazepine use. Parr JM; Kavanagh DJ; Young RM; Mitchell G Drug Alcohol Rev; 2011 May; 30(3):306-14. PubMed ID: 21545562 [TBL] [Abstract][Full Text] [Related]
26. The benzodiazepine withdrawal syndrome and its management. Onyett SR J R Coll Gen Pract; 1989 Apr; 39(321):160-3. PubMed ID: 2576073 [TBL] [Abstract][Full Text] [Related]
28. [Benzodiazepine dependence: addiction potential of the benzodiazepines is greater than previously assumed (author's transl)]. Kemper N; Poser W; Poser S Dtsch Med Wochenschr; 1980 Dec; 105(49):1707-12. PubMed ID: 7439058 [TBL] [Abstract][Full Text] [Related]
29. [Benzodiazepines to people with substance abuse problems?]. Waal H; Bramness JG Tidsskr Nor Laegeforen; 2010 Mar; 130(6):610-2. PubMed ID: 20349006 [TBL] [Abstract][Full Text] [Related]
30. Benzodiazepine dependence of several years duration: clinical profile and therapeutic benefits. Tennant FS; Pumphrey EA NIDA Res Monogr; 1984; 55():211-6. PubMed ID: 6443381 [TBL] [Abstract][Full Text] [Related]
31. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles. Hood S; O'Neil G; Hulse G J Psychopharmacol; 2009 Jun; 23(4):401-9. PubMed ID: 19164495 [TBL] [Abstract][Full Text] [Related]
32. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it. Prescrire Int; 2007 Feb; 16(87):24-31. PubMed ID: 17323538 [TBL] [Abstract][Full Text] [Related]
33. Benzodiazepine dependence: management of discontinuation. Rickels K; Case WG; Schweizer E; Garcia-Espana F; Fridman R Psychopharmacol Bull; 1990; 26(1):63-8. PubMed ID: 1973546 [TBL] [Abstract][Full Text] [Related]
34. [Benzodiazepine addiction]. Vujosević K; Nikić S; Marković M; Preradović M; Miljanović B Vojnosanit Pregl; 1983; 40(6):446-7, 452. PubMed ID: 6141668 [No Abstract] [Full Text] [Related]
35. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. McDonough M; Kennedy N; Glasper A; Bearn J Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884 [TBL] [Abstract][Full Text] [Related]
36. Office treatment of barbiturate and amphetamine dependence. Senseman LA Med Times; 1973 Apr; 101(4):65-74. PubMed ID: 4735029 [No Abstract] [Full Text] [Related]
38. [The withdrawal syndrome in benzodiazepine dependence and its management]. Străulea AO; Chiriţă V Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):879-84. PubMed ID: 20191849 [TBL] [Abstract][Full Text] [Related]
39. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods. McGregor C; Machin A; White JM Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904 [TBL] [Abstract][Full Text] [Related]
40. Identification and management of benzodiazepine dependence. Tyrer PJ; Seivewright N Postgrad Med J; 1984; 60 Suppl 2():41-6. PubMed ID: 6146970 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]